Viewing StudyNCT00496015

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 6:30 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00496015
Status: COMPLETED
Last Update Posted: 2019-01-18
First Post: 2007-07-03
Brief Title: Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Infections Streptococcal
Keywords:
Name View
Booster vaccination View
Streptococcus Pneumoniae Vaccines View
Meningococcal disease View
Carriage View
Prophylactic antipyretic View
Safety View
Pneumococcal vaccine View
Fever View
Pneumococcal disease View
Immunogenicity View
Meningococcal vaccine View